title: Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president's emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique.
abstract: Many countries in sub-Saharan Africa have made antiretroviral therapy (ART) available in urban settings, but the progress of treatment expansion into rural Africa has been slower. We analysed routine data for patients enrolled in a rural HIV treatment programme in Zambézia Province, Mozambique (1 June 2006 through 30 March 2009). There were 12,218 patients who were ≥15 years old enrolled (69% women). Median age was 25 years for women and 31 years for men. Older age and higher level of education were strongly predictive of ART initiation (P < 0.001). Patients with a CD4+ count of 350 cells/μL versus 50 cells/μL were less likely to begin ART (odds ratio [OR]: 0.19, 95% confidence interval [CI]: 0.16-0.23). In rural sub-Saharan Africa, HIV testing, linkage to care, logistics for ART initiation and fears among some patients to take ART require specialized planning to maximize successes. Sustainability will require improved health manpower, infrastructure, stable funding, continuous drug supplies, patient record systems and, most importantly, community engagement.
authors.affiliation: Vanderbilt Institute for Global Health and Departments of Pediatrics, Biostatistics, and Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. troy.moon@fgh.org.mz
authors.forename: T D
authors.initials: TD
authors.lastname: Moon
authors.forename: J R
authors.initials: JR
authors.lastname: Burlison
authors.forename: M
authors.initials: M
authors.lastname: Blevins
authors.forename: B E
authors.initials: BE
authors.lastname: Shepherd
authors.forename: A
authors.initials: A
authors.lastname: Baptista
authors.forename: M
authors.initials: M
authors.lastname: Sidat
authors.forename: A E
authors.initials: AE
authors.lastname: Vergara
authors.forename: S H
authors.initials: SH
authors.lastname: Vermund
mesh_terms: D000328:Adult; D000349:Africa; D000367:Age Factors; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D004363:Drug Utilization / Q000706:statistics & numerical data*; D004493:Education / Q000706:statistics & numerical data; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology* / Q000473:pathology; D006297:Health Services Accessibility / Q000706:statistics & numerical data*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009073:Mozambique / Q000453:epidemiology; D012424:Rural Population
chemical_list: D019380:Anti-HIV Agents